GET IN TOUCH

Mitigating Oestrogen Blockade in Breast Cancer

Oestrogen-blocking treatments such as tamoxifen and aromatase inhibitors are commonly […]
Oestrogen blockade in breast cancer involves reducing or blocking oestrogen to prevent recurrence, which can cause side effects, such as hot flushes, joint pain, dryness and bone loss.

Oestrogen-blocking treatments such as tamoxifen and aromatase inhibitors are commonly used for hormone-receptor-positive breast cancer because they lower or block oestrogen, helping prevent cancer recurrence. As oestrogen also plays a role in bone strength, metabolism, cardiovascular health, sexual comfort and emotional well-being, its reduction can lead to a range of treatment-related symptoms.

Supportive management helps women tolerate these therapies more comfortably by protecting bone and metabolic health, easing menopausal symptoms and maintaining quality of life throughout long-term treatment.

What is oestrogen blockade? 

Oestrogen blockade refers to treatments that lower or block oestrogen in order to reduce the chance of breast cancer returning. Since hormone-receptor-positive breast cancers rely on oestrogen for growth, reducing this hormone is a key part of long-term therapy.

  • How oestrogen-blocking therapies work — these treatments reduce oestrogen levels or prevent cancer cells from responding to it, helping stop residual cancer cells from growing.
  • Hormonal changes and timelines — Oestrogen levels typically fall within weeks of starting therapy, and the effects continue throughout the recommended five to ten years of treatment.

Why are the effects of low oestrogen levels? 

Oestrogen-blocking therapy is essential for reducing breast cancer recurrence, but the drop in oestrogen can cause symptoms that affect daily comfort, long-term health and treatment adherence. Mitigation helps manage these effects so women can continue therapy safely and comfortably.

  • Mood changes and sleep disturbance — irritability, low mood and disrupted rest caused by hormonal shifts.

How is monitoring performed during oestrogen blockage? 

Regular monitoring helps ensure that oestrogen-blocking treatments remain safe, effective and well tolerated. These assessments identify early changes in bone, metabolic and cardiovascular health so that supportive care can be introduced when needed.

  • Bone density scans (DEXA) — evaluating bone strength and tracking changes that may require treatment.
  • Hormone-related blood tests — checking relevant markers when clinically appropriate to guide therapy decisions.
  • Cardiovascular risk assessment — reviewing cholesterol, blood pressure and glucose levels for early signs of metabolic change.
  • Review of menopausal symptoms — monitoring hot flushes, sleep quality and other treatment-related effects.
  • Monitoring joint and musculoskeletal health — identifying persistent pain or stiffness that may need additional intervention.

Medical strategies for mitigating oestrogen-blockade effects

A targeted medical approach helps reduce the physical impact of low oestrogen and supports adherence to breast cancer therapy. These strategies focus on bone health, symptom control and personalised adjustments to treatment when necessary.

Medication-based approaches 

  • Non-hormonal therapies for hot flushes — medications that ease temperature changes without affecting cancer treatment.
  • Treatments for joint pain — options such as analgesics or targeted therapies to relieve aromatase-inhibitor-related discomfort.
  • Local vaginal oestrogen (oncologist-approved) — low-dose treatments that relieve dryness and irritation with minimal systemic absorption.
  • Adjustments between tamoxifen and aromatase inhibitors — switching medications when side effects significantly affect quality of life.

Hormonal considerations 

  • Ovarian suppression or removal — options for premenopausal women requiring more complete hormonal blockade.
  • Assessing suitability for changing regimens — reviewing tolerance and effectiveness to determine if a different therapy is appropriate.
  • Oncology–endocrinology collaboration — joint decision-making to balance cancer control with hormone-related health concerns. 

Lifestyle and supportive measures during oestrogen blockage

Lifestyle changes play a key role in reducing the side effects of oestrogen-blocking therapy. Structured exercise, balanced nutrition and supportive routines help protect bone and metabolic health while improving overall quality of life.

  • Resistance and strength training — builds muscle strength, supports bone density and improves physical stamina.
  • Cardiovascular exercise — helps manage weight, enhances heart health and reduces fatigue. 
  • Nutrition for bone and metabolic health — emphasises calcium, vitamin D, protein and heart-healthy foods to stabilise metabolism. 
  • Weight management guidance — strategies to reduce abdominal fat gain and maintain healthy body composition. 
  • Stress management and sleep hygiene — practices that improve emotional well-being and support restorative sleep. 
  • Smoking and alcohol reduction — measures that benefit bone strength, cardiovascular health and overall treatment tolerance. 

Managing sexual health during oestrogen blockage therapy 

Low oestrogen levels can affect sexual comfort, intimacy and emotional well-being. Supportive strategies help manage these changes so women can maintain confidence and quality of life throughout treatment.

  • Lubricants and vaginal moisturisers — non-hormonal options that ease dryness and improve comfort during intimacy.
  • Localised therapies for dryness (oncologist-approved) — low-dose treatments that relieve irritation with minimal systemic hormone absorption.
  • Pelvic floor therapy — techniques that improve pelvic comfort, reduce pain and support sexual function.
  • Counselling for intimacy and relationships — guidance to help couples navigate changes in libido or sexual comfort.
  • Referral to psychosexual specialists — additional support for women experiencing persistent pain, low desire or distress.

Managing bone and cardiovascular health during oestrogen blockage therapy 

Oestrogen plays a key role in bone density and metabolic stability. When levels fall during treatment, proactive monitoring and early intervention help prevent fractures, heart risks and metabolic complications.

  • Calcium and vitamin D optimisation — ensuring adequate intake to support bone strength and reduce fracture risk. 
  • Regular bone-density monitoring — DEXA scans to track bone loss and guide timely treatment decisions. 
  • Strategies to reduce cardiovascular and metabolic risks — exercise, nutrition and medical review to manage blood pressure, cholesterol and glucose. 
  • Screening for diabetes and cholesterol changes — routine tests to detect early metabolic shifts linked to oestrogen reduction. 

When to adjust therapy or seek specialist care? 

Some women may develop symptoms or health concerns that warrant treatment adjustments or additional specialist input. Early review helps maintain comfort, safety and adherence throughout long-term therapy.

  • Severe joint pain — persistent or debilitating discomfort that affects mobility or daily activities. 
  • Rapid bone loss or recurrent fractures — signs that additional bone-strengthening treatment may be needed. 
  • Intolerable menopausal symptoms — hot flushes, sleep disturbance or mood shifts that significantly impact quality of life. 
  • New cardiovascular symptoms — chest discomfort, rising blood pressure or changes in heart rhythm requiring assessment. 
  • Concerns about adherence or side effects — difficulty tolerating medication or uncertainty about continuing therapy. 
  • Need for multidisciplinary care — complex cases that benefit from coordinated oncology, endocrinology, cardiology or gynaecology input. 

Potential benefits of a mitigation plan 

A structured mitigation plan helps women manage the side effects of oestrogen blockade more effectively. By combining medical treatments with lifestyle support, many women experience better comfort, health stability and quality of life throughout therapy.

  • Better tolerance of long-term therapy — reduced symptoms help women stay on treatment as recommended. 
  • Reduced musculoskeletal pain — targeted interventions ease joint aches and stiffness. 
  • Improved bone strength — bone-protective strategies lower the risk of fractures. 
  • More stable emotional well-being — support for mood and sleep helps maintain daily functioning. 
  • Better sexual comfort — targeted care relieves dryness, irritation and discomfort during intimacy. 
  • Enhanced overall quality of life — a holistic approach supports physical, emotional and social well-being. 

Summary

Oestrogen-blocking therapy is a vital part of managing hormone-receptor-positive breast cancer, but the resulting drop in oestrogen can lead to symptoms that affect physical comfort, emotional well-being and long-term health. With the right mitigation plan, many of these effects can be managed effectively. Medical strategies such as bone-protective treatment, non-hormonal symptom support and carefully chosen medication adjustments work alongside lifestyle measures to protect bone health, stabilise metabolism, improve sexual comfort and support emotional balance. Regular monitoring ensures that changes are identified early and addressed promptly, helping women stay on their cancer therapy with greater confidence and ease.

If you are experiencing side effects from oestrogen-blocking treatment for breast cancer or would like a check for the side-effects of oestrogen lowering, schedule a consultation with The Metabolic Clinic to explore personalised strategies that support your bone, metabolic, emotional and sexual health throughout therapy.

Frequently Asked Questions (FAQs) 

Yes. Some symptoms settle as the body adapts, while others can be managed effectively with medical or lifestyle interventions.

Yes. Regular resistance and cardiovascular exercise can reduce fatigue, ease joint discomfort and support bone and metabolic health.

No. Side effects vary widely; some women experience only mild changes, while others benefit from additional supportive care.

In premenopausal women, ovarian suppression may temporarily halt ovarian function. Fertility planning should be discussed with oncology and reproductive specialists.

No. Joint pain is a common side effect of aromatase inhibitors and does not indicate poorer cancer control. It can often be managed successfully.

Yes. Non-hormonal moisturisers and lubricants are safe and effective. Low-dose local oestrogen may be an option if approved by an oncologist.

Non-hormonal treatments, lifestyle changes and medication review can help. A specialist can guide the safest and most effective options.

It may influence cholesterol, blood pressure or glucose control. Regular monitoring and lifestyle measures help protect cardiovascular health.

No. Weight gain can occur, but structured exercise, nutrition guidance and metabolic monitoring help maintain a healthy body composition.

Yes. Many women find that concentration, memory and clarity improve with sleep support, stress management and physical activity.

Switching may be considered if side effects significantly limit daily function. This decision should be guided by your oncologist.

Not always. They are recommended based on bone density results and individual risk of fracture.

Yes. Lubricants, moisturisers and pelvic floor therapy are effective. If symptoms persist, oncologist-approved local options may help.

Most women have regular reviews every 3–6 months, with periodic bone, metabolic and cardiovascular assessments depending on clinical needs.

chat with us

Welcome to The Metabolic Clinic

Holistic Care for Hormones, Bones, and Metabolic Health
Make An Appointment Now

related services

Services

Diabetes

read more

Weight Management & Nutritional Counselling

read more

Meet Our Doctor

Dr Dinesh Carl
Junis Mahendran

MBBS (Hons), FRACP (Australia)

Dr Dinesh graduated with honours from Monash University, Melbourne in 2009, receiving the Prince Henry's Prize in Surgery. During his endocrinology training in Melbourne, he won the top registrar award at the Endocrine Society of Australia Clinical Weekend in 2016, followed by securing Australia's only Andrology fellowship in 2017. Upon returning to Singapore, he was the sub-speciality lead for adrenal, pituitary, and bone services at Khoo Teck Puat Hospital and established The Metabolic Bone Clinic.

A passionate educator, he served as Associate Programme Director for Endocrinology at NHG, training the next generation of endocrinologists, and received the NHG Teaching Award for Senior Doctors in 2023. An expert endocrinologist with proficiency in both general and sub-speciality endocrinology, he has an interest in longevity through improving cardiovascular risk, metabolism, bone health, and muscle loss prevention, with the ultimate aim of improving the number of healthy years in one's life.

10+ Years of
Experience in Hormone & Metabolic Health
Founder of The Metabolic Bone Clinic in Khoo Teck Puat Hospital
Sub-specialist training with international experts in Melbourne, Australia
Clinical Interest in Longevity & Metabolic Health

START YOUR PERSONALISED HEALTH JOURNEY

If you’re not achieving your treatment targets, struggling with weight changes, fatigue, or unexplained symptoms—it’s time to take a deeper look.



Get clarity with a tailored plan built around you and improving your metabolic health.





    Contact Information

    MONDAY - FRIDAY
    8:30 am to 5:30 pm

    SATURDAY
    8:30 am – 12:30 pm

    Closed on Sun and PH

    © 2026 The Metabolic Clinic. All rights reserved.